Cizzle Biotechnology Holdings Plc (LON:CIZ – Get Free Report)’s share price was down 12.3% during trading on Monday . The company traded as low as GBX 3.19 and last traded at GBX 3.19. Approximately 1,175,647 shares traded hands during trading, a decline of 6% from the average daily volume of 1,247,026 shares. The stock had previously closed at GBX 3.63.
Cizzle Biotechnology Stock Performance
The business has a fifty day simple moving average of GBX 2.28 and a 200-day simple moving average of GBX 1.82. The firm has a market cap of £12.19 million, a price-to-earnings ratio of -18.09 and a beta of 0.07.
Cizzle Biotechnology (LON:CIZ – Get Free Report) last posted its earnings results on Tuesday, May 5th. The company reported GBX (0.17) earnings per share for the quarter.
Cizzle Biotechnology Company Profile
Cizzle Biotechnology Holdings Plc, together with its subsidiaries, engages in the development of an immunoassay test for the CIZ1B biomarker for the early detection of lung cancer in the United Kingdom. The company was formerly known as Cizzle Biotechnology Limited and changed its name to Cizzle Biotechnology Holdings Plc in May 2021. Cizzle Biotechnology Holdings Plc is headquartered in London, the United Kingdom.
Read More
- Five stocks we like better than Cizzle Biotechnology
- Why Applied Optoelectronics Stock May Be Near a Turning Point
- From High-Yield to High-Growth: 3 Stocks Boosting Dividends
- Is Everspin Technologies the Next AI Edge Breakout?
- 5 Robotics Stocks to Watch as Physical AI Builds Momentum
Receive News & Ratings for Cizzle Biotechnology Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cizzle Biotechnology and related companies with MarketBeat.com's FREE daily email newsletter.
